CD40 and ovarian neoplasm: MoDCs readily engulfed HOCl-oxidized SKOV3 ovarian tumor cells, and when matured with either monophosphoryl lipid A or anti-CD40 activating antibody, they could stimulate strong T cell responses directed against specific ovarian tumor-associated antigens such as HER-2/neu and MUC1.